Evidence map›Paper›PMID 20581062›Full record

ArticleThe American journal of pathology2010

Abnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin.

Tchilalo Boukpessi, Celine Gaucher, Thibaut Léger, Benjamin Salmon, Julie Le Faouder, Cyril Willig, Peter S Rowe, Michèle Garabédian, Olivier Meilhac, Catherine Chaussain

Open access · hybridAbstract read
In one paragraph

Article in The American journal of pathology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Cementum Attachment Protein-Derived Peptides Modulate Brushite and Calcium Oxalate Crystallization In Vitro.Journal of peptide science : an official publication of the European Peptide Society · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. PHEXGenes · 2022
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The rachitic tooth.Endocrine reviews · 2014
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Tchilalo BoukpessiFaculté de Chirurgie Dentaire, Université Paris Descartes, EA 2496, Montrouge, France.
Celine Gaucher
Thibaut Léger
Benjamin Salmon
Julie Le Faouder
Cyril Willig
Peter S Rowe
Michèle Garabédian
Olivier Meilhac
Catherine Chaussain
Délégation Paris 5 · FRInserm · FRUniversité Claude Bernard Lyon 1 · FRUniversity of Kansas Medical Center · US

Funding

Mineralization of the matrix in disease and healthR01AR051598 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI ROWE, PETER S · 2004 to 2013
$2.8M
NIAMS NIH HHS R01 AR051598NIAMS NIH HHS R01-AR051598
6 · The paper itself

Abstract

Severe dental troubles are associated with X-linked hypophosphatemic rickets and are mainly related to impaired dentin mineralization. In dentin matrix, matrix extracellular phosphoglycoprotein (MEPE) may be protected from proteolysis by a specific interaction with PHEX (phosphate regulating gene with homologies to endopeptidases on the X chromosome). The objective of our work was to determine whether PHEX impairment induces MEPE cleavage in dentin and the subsequent release of the C-terminal acidic serine- and aspartate-rich motif (ASARM) peptide, which is known to inhibit mineralization. By Western blot analysis, we explored dentin extracts from seven hypophosphatemic patients with mutations of the PHEX gene. A proteomic approach combining immunoprecipitation, surface-enhanced laser desorption/ionization-time of flight-mass spectrometry and matrix-assisted laser desorption ionization-time of flight analysis of the samples completed this exploration. This study shows a 4.1-kDa peptide containing the MEPE-derived ASARM peptide in hypophosphatemic samples. The presence of ASARM was less marked in patients treated with 1-hydroxylated vitamin D and phosphate during growth. Moreover, recombinant ASARM implanted in a rat pulp injury model disturbed the formation of the reparative dentin bridge. These results suggest that abnormal MEPE cleavage occurs when PHEX activity is deficient in humans, the ASARM peptide may be involved in the mineralization defects and the PHEX-MEPE interaction may be indirect, as ensuring a better phosphate and vitamin D environment to the mineralizing dentin prevents MEPE cleavage.

Indexed as

Genetic Diseases, X-LinkedAdolescentAdultAmino Acid SequenceAnimalsCalcification, PhysiologicChildChild, PreschoolCholecalciferolDentinExtracellular Matrix ProteinsFamilial Hypophosphatemic RicketsFemaleGlycoproteinsHumansMaleCholecalciferolExtracellular Matrix ProteinsGlycoproteinsMEPE protein, humanPeptidesPHEX Phosphate Regulating Neutral EndopeptidasePhosphoproteinsVitamins

Identifiers

PMID20581062
PMCPMC2913338
OpenAlexW2097460528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.